BTN2A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.600000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.525800E-01
Normal-vs-Stage2
4.651800E-01
Normal-vs-Stage3
2.081000E-01
Normal-vs-Stage4
5.248400E-01
Stage1-vs-Stage2
9.054000E-01
Stage1-vs-Stage3
2.392000E-01
Stage1-vs-Stage4
3.120400E-01
Stage2-vs-Stage3
3.165000E-01
Stage2-vs-Stage4
4.793200E-01
Stage3-vs-Stage4
1.376850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.635200E-01
Normal-vs-AfricanAmerican
4.920800E-01
Normal-vs-Asian
1.518180E-01
Caucasian-vs-AfricanAmerican
8.684200E-01
Caucasian-vs-Asian
5.550200E-01
AfricanAmerican-vs-Asian
6.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.708000E-01
Normal-vs-Female
4.502800E-01
Male-vs-Female
6.666200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.303800E-01
Normal-vs-Age(41-60Yrs)
5.457800E-01
Normal-vs-Age(61-80Yrs)
4.266400E-01
Normal-vs-Age(81-100Yrs)
4.373000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.572400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.949800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.845200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.930140E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.978790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.637000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.095200E-01
Normal-vs-Daily Drinker
3.488400E-01
Normal-vs-Weekly Drinker
4.181000E-01
Normal-vs-Occasional Drinker
4.892200E-01
Normal-vs-Social Drinker
4.390000E-01
Non Drinker-vs-Daily Drinker
3.367600E-01
Non Drinker-vs-Weekly Drinker
9.399400E-01
Non Drinker-vs-Occasional Drinker
3.333400E-01
Non Drinker-vs-Social Drinker
7.072200E-01
Daily Drinker-vs-Weekly Drinker
3.477800E-01
Daily Drinker-vs-Occasional Drinker
5.104000E-02
Daily Drinker-vs-Social Drinker
1.695580E-01
Weekly Drinker-vs-Occasional Drinker
4.224800E-01
Weekly Drinker-vs-Social Drinker
7.780200E-01
Occasional Drinker-vs-Social Drinker
5.461800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.559760E-01
Normal-vs-Grade 2
6.251700E-02
Normal-vs-Grade 3
4.666100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.377190E-01
Grade 1-vs-Grade 3
2.608600E-01
Grade 1-vs-Grade 4
1.559760E-01
Grade 2-vs-Grade 3
6.681200E-01
Grade 2-vs-Grade 4
6.251700E-02
Grade 3-vs-Grade 4
4.666100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.835410E-01
Normal-vs-NonDiabetic
4.402200E-01
Diabetic-vs-NonDiabetic
7.450600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.687800E-01
Normal-vs-NoPancreatitis
4.420600E-01
Pancreatitis-vs-NoPancreatitis
8.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.708000E-01
Normal-vs-N1
4.588800E-01
N0-vs-N1
8.145000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.771600E-01
Normal-vs-TP53-NonMutant
1.450200E-01
TP53-Mutant-vs-TP53-NonMutant
7.035600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
